Patients will work with their Injectco provider to determine the right diet and exercise changes
Clinics sometimes include GACLIV as part of IV therapy or amino acid wellness programs
Why do GLP-1 medications cause facial changes
Part D enrollees using a GLP-1 for type 2 diabetes, sleep apnea, or other Medicare-covered uses will continue accessing the drug through their Part D plan and paying their plans cost-sharing requirement, even if its more than the $50 copayment for GLP-1s for obesity under the Medicare GLP-1 Bridge
However, most subsequent clinical research has focused on androgenetic alopecia specifically, so the strongest evidence base is for pattern hair loss
Crucially, GIP agonism helps buffer the nausea often associated with strong GLP-1 stimulation, allowing for better tolerance at higher dosages